• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服活性氨基官能化抗疟1,2,4-三恶烷。

Orally active amino functionalized antimalarial 1,2,4-trioxanes.

作者信息

Singh Chandan, Malik Heetika, Puri Sunil K

机构信息

Division of Medicinal Chemistry, Central Drug Research Institute, -226001, Lucknow, India.

出版信息

Bioorg Med Chem Lett. 2004 Jan 19;14(2):459-62. doi: 10.1016/j.bmcl.2003.10.051.

DOI:10.1016/j.bmcl.2003.10.051
PMID:14698181
Abstract

Using readily available trioxanes 6a-b, a new series of amino functionalized 1,2,4-trioxanes 8a-e and 9a-e have been prepared and evaluated for antimalarial activity against multi-drug resistant Plasmodium yoelii in Swiss mice model. Several of these novel trioxanes are orally more active than the parent trioxanes 6a-b. Antimalarial activity of amino functionalized trioxane 9a, the most potent compound in the series, is very close to that of beta-arteether.

摘要

利用易于获得的三恶烷6a - b,制备了一系列新的氨基官能化1,2,4 - 三恶烷8a - e和9a - e,并在瑞士小鼠模型中针对多药耐药的约氏疟原虫进行了抗疟活性评估。这些新型三恶烷中有几种口服活性比母体三恶烷6a - b更高。该系列中最有效的化合物——氨基官能化三恶烷9a的抗疟活性与蒿甲醚非常接近。

相似文献

1
Orally active amino functionalized antimalarial 1,2,4-trioxanes.口服活性氨基官能化抗疟1,2,4-三恶烷。
Bioorg Med Chem Lett. 2004 Jan 19;14(2):459-62. doi: 10.1016/j.bmcl.2003.10.051.
2
Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.口服活性1,2,4-三恶烷:针对小鼠体内多重耐药性约氏疟原虫尼氏亚种的一系列新型9-官能化3-(1-芳基乙烯基)-1,2,5-三氧杂螺[5.5]十一烷的合成与抗疟评估
J Med Chem. 2006 May 4;49(9):2794-803. doi: 10.1021/jm051130r.
3
Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice.新型双-和三-1,2,4-三恶烷:瑞士小鼠体内对多重耐药约氏疟原虫的合成及抗疟活性
J Med Chem. 2008 Dec 11;51(23):7581-92. doi: 10.1021/jm801006v.
4
Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes.合成及具有口服活性的氨基官能化螺 1,2,4-三噁烷类抗疟药物的评估。
J Med Chem. 2010 Nov 11;53(21):7587-98. doi: 10.1021/jm100678p.
5
Novel saturated 1,2,4-trioxanes and their antimalarial activity against multidrug resistant Plasmodium yoelii nigeriensis in Swiss mice model via oral route.新型饱和 1,2,4-三恶烷及其通过口服途径在瑞士小鼠模型中抗耐多药恶性疟原虫尼日利亚株的抗疟活性。
Bioorg Med Chem Lett. 2024 Aug 1;108:129801. doi: 10.1016/j.bmcl.2024.129801. Epub 2024 May 20.
6
Synthesis of novel 1,2,4-trioxanes and antimalarial evaluation against multidrug-resistant Plasmodium yoelii nigeriensis.新型1,2,4-三恶烷的合成及其对多重耐药性约氏疟原虫尼日尔株的抗疟活性评价
Bioorg Med Chem Lett. 2021 Oct 1;49:128305. doi: 10.1016/j.bmcl.2021.128305. Epub 2021 Aug 6.
7
New orally active spiro 1,2,4-trioxanes with high antimalarial potency.具有高抗疟效力的新型口服活性螺环[1,2,4]三恶烷
Bioorg Med Chem Lett. 2005 Oct 15;15(20):4484-7. doi: 10.1016/j.bmcl.2005.07.013.
8
Orally active antimalarials: synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice.口服活性抗疟药:针对小鼠多药耐药疟疾的一系列新型甾体基1,2,4-三氧杂环己烷的合成与生物评价
Bioorg Med Chem Lett. 2007 Aug 1;17(15):4097-101. doi: 10.1016/j.bmcl.2007.05.055. Epub 2007 May 23.
9
Synthesis of new 6-alkylvinyl/arylalkylvinyl substituted 1,2,4-trioxanes active against multidrug-resistant malaria in mice.新型6-烷基乙烯基/芳基烷基乙烯基取代的1,2,4-三恶烷的合成及其对小鼠耐多药疟疾的活性研究
Bioorg Med Chem. 2004 Nov 1;12(21):5553-62. doi: 10.1016/j.bmc.2004.08.005.
10
New orally active diphenylmethyl-based ester analogues of dihydroartemisinin: Synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice.新型口服活性二氢青蒿素二苯甲基酯类似物的合成及其对小鼠耐多药约氏疟原虫尼日尔株的抗疟活性评估
Bioorg Med Chem Lett. 2016 Mar 15;26(6):1536-1541. doi: 10.1016/j.bmcl.2016.02.019. Epub 2016 Feb 9.

引用本文的文献

1
Mechanistic Evaluation of the Stability of Arylvinyl-1,2,4-trioxanes under Acidic Conditions for Their Oral Administration as an Antimalarial Drug.作为抗疟药物口服给药时芳基乙烯基-1,2,4-三恶烷在酸性条件下稳定性的机理评估
ACS Omega. 2022 May 17;7(21):17984-17994. doi: 10.1021/acsomega.2c01321. eCollection 2022 May 31.
2
Synthetic Approaches to Mono- and Bicyclic Perortho-Esters with a Central 1,2,4-Trioxane Ring as the Privileged Lead Structure in Antimalarial and Antitumor-Active Peroxides and Clarification of the Peroxide Relevance.以中心1,2,4-三氧杂环己烷环为抗疟和抗肿瘤活性过氧化物中特权先导结构的单环和双环过原酸酯的合成方法及过氧化物相关性的阐明
Molecules. 2017 Jan 11;22(1):119. doi: 10.3390/molecules22010119.
3
Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
内过氧化物抗疟药:基于1,2,4-三恶烷结构支架的开发、结构多样性及药效学方面
Drug Des Devel Ther. 2016 Nov 1;10:3575-3590. doi: 10.2147/DDDT.S118116. eCollection 2016.
4
Pharmacokinetic study and bioavailability of a novel synthetic trioxane antimalarial compound 97/63 in rats.新型合成三恶烷抗疟化合物97/63在大鼠体内的药代动力学研究及生物利用度
Malar Res Treat. 2014;2014:759392. doi: 10.1155/2014/759392. Epub 2014 Sep 11.
5
Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes.3,3-螺环缩合的5,6-二取代1,2,4-三恶烷的合成及其抗疟活性
ACS Med Chem Lett. 2012 Dec 11;4(2):165-9. doi: 10.1021/ml300188t. eCollection 2013 Feb 14.
6
Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug.CDRI-97/78的单次递增剂量安全性和药代动力学:一种新型抗疟药物的首次人体研究。
Malar Res Treat. 2014;2014:372521. doi: 10.1155/2014/372521. Epub 2014 Mar 27.
7
Synthesis of five- and six-membered cyclic organic peroxides: Key transformations into peroxide ring-retaining products.五元环和六元环环状有机过氧化物的合成:保留过氧环产物的关键转化。
Beilstein J Org Chem. 2014 Jan 8;10:34-114. doi: 10.3762/bjoc.10.6.
8
1,2,5,10,11,14-hexaoxadispiro[5.2.5.2]hexadecanes: novel spirofused bis-trioxane peroxides.1,2,5,10,11,14-六氧杂双螺[5.2.5.2]十六烷:新型螺稠合双三氧杂环乙烷过氧化物
Molecules. 2008 Aug 19;13(8):1743-58. doi: 10.3390/molecules13081743.